Dr. Jason James Eckel, MD

Dr. Eckel practices at North Carolina Nephrology PA - HOPD in Cary, North Carolina.

Dr. Eckel's NPI, 1801079884, was assigned on December 12, 2007. Dr. Eckel graduated from Ohio State University College of Medicine in 2004. Dr. Eckel holds North Carolina license 2007-01846.

Dr. Eckel's primary practice is North Carolina Nephrology PA - HOPD, at 790 SE Cary Pkwy, Cary, NC 27511.

Dr. Eckel's primary practice is North Carolina Nephrology PA - HOPD in Cary, North Carolina. Dr. Eckel is also affiliated with WakeMed Cary Hospital. The medical group on file is North Carolina Nephrology, P.A. Dmand AI also links Dr. Eckel to 3 more hospitals, 4 dialysis centers and 1 group practice or clinic, each named with a free account. Dr. Eckel's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Eckel practices, 10 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Eckel's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Eckel is board certified in nephrology by the American Board of Internal Medicine. Dr. Eckel is licensed in North Carolina.

Dmand AI lists acute kidney failure, chronic kidney disease, fluid and electrolyte imbalances and hypercalcemia among the conditions Dr. Eckel treats.

CMS data shows 1,946 Medicare services from Dr. Eckel across 15 procedure codes in 2024, for 488 Medicare patients. Medicare paid $217,590 for them.

CMS counts 488 Medicare patients who saw Dr. Eckel in 2024. The largest group is 75 to 84, with 208 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 17% are also on Medicaid. Their average risk score is 4.50, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Eckel's median patient age at 71, with 48% women.

In 2024, Dr. Eckel wrote 1,951 Medicare Part D claims for 324 patients. 83% of them were for generic drugs. CMS names the drug for 1,531 of them, across 51 drugs with 11 or more claims each, at $476,757 in total drug cost. In 2023, CMS named 1,236 claims across 45 drugs.

Dr. Eckel accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Eckel as offering telehealth.

Dmand AI links 8 papers to Dr. Eckel, published from 2008 to 2022. 2010 was the busiest year, with 2. The most frequent topics are Glomerulosclerosis, Focal Segmental, Kidney and Mutation, Missense. Dr. Eckel has published most often in J Am Soc Nephrol. Dr. Eckel's most frequent co-authors are Rasheed A. Gbadegesin, MD, Peter Joseph Lavin, MD and Frederick Scott Jones, MD.

Dmand AI links Dr. Eckel to 3 clinical trials, 2 of them phase 3 studies. 1 is still active or recruiting. Conditions studied include Polycystic Kidney, Autosomal Dominant, Nephritis, Hereditary and Polycystic Kidney Diseases. Biogen sponsors the most, 2.

CMS Open Payments shows 752 general payments to Dr. Eckel from 36 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 66% of the total. Otsuka America Pharmaceutical, Inc. paid the most, $114,449.

Dr. Eckel graduated from Ohio State University College of Medicine in 2004. Dr. Eckel is a member of ASN.

Dr. Eckel is in network with 19 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.